Cancer Research UK invests £45 million in clinical trials

Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK to test new treatments.

As one of the charity’s largest investments in clinical research to date, the investment will be divided across eight clinical trial units in Cardiff, Birmingham, Glasgow, Southampton, Leeds and London (at The Institute of Cancer Research, London, UCL, and Queen Mary University of London). In Birmingham, there will be dedicated funding for finding new treatments for children with cancer.

Charles Swanton, Cancer Research UK’s chief clinician, said: “Our clinical research enables us to translate discoveries from the lab in order to improve cancer diagnostics and treatments, giving more patients the best chance of beating their disease. This is particularly important for patients with hard to treat cancers, including pancreatic, oesophageal, lung and brain tumours, where options for treatment are limited and survival rates remain poor.”

Each year, around 25,000 people take part in a clinical trial that’s supported by Cancer Research UK.

Supplier Profiles